分组1 - Viatris reported quarterly earnings of $0.57 per share, exceeding the Zacks Consensus Estimate of $0.52 per share, and showing an increase from $0.54 per share a year ago, resulting in an earnings surprise of +9.62% [1] - The company achieved revenues of $3.7 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 5.29%, and up from $3.53 billion year-over-year [2] - Viatris has consistently outperformed consensus EPS and revenue estimates over the last four quarters, indicating strong financial performance [2] 分组2 - The stock has increased approximately 29.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.5% [3] - The current consensus EPS estimate for the upcoming quarter is $0.58 on revenues of $3.31 billion, and for the current fiscal year, it is $2.50 on revenues of $14.34 billion [7] - The Zacks Industry Rank places Medical Services in the bottom 39% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8]
Viatris (VTRS) Surpasses Q4 Earnings and Revenue Estimates